Contact PT-141 Compound.

Editorial inquiries and corrections

PT-141 Compound is an editorial digest, and accuracy is the whole point. If you believe a study has been summarized incorrectly, a citation is broken, or a finding has been superseded by newer published work, we want to know. Use the form below to send a correction or a source question. Please include the page, the specific claim, and the citation or identifier (DOI, PMID, or NCT) where you can — that makes a fix fast and verifiable.

We also welcome notes on clarity: if a section reads as too technical or buries the plain-English point, that is useful feedback, and the site is written to be readable as well as cited.

What we cannot help with

We cannot answer personal medical questions, advise whether PT-141 or bremelanotide is appropriate for anyone, suggest a dose, or help anyone obtain any compound. We are not a clinic and we do not employ clinicians; questions about whether a drug applies to a specific person belong with a licensed healthcare professional who can assess that person directly.

We also do not sell, source, or distribute PT-141 or any other product, and we cannot make referrals to anyone who does. Inquiries of that kind will not receive a response. The honest tolerability and contraindication record — including the cardiovascular caution — lives on PT-141 side effects and tolerability for readers who want the cited safety picture.

Send a message

Use the form to reach the editorial desk with a correction, a source question, or a clarity note. Fields: your name, an email address for a reply, and your message. We read everything that concerns the accuracy or readability of the digest.